tma medical abbreviation - SPORTS
Thrombotic Microangiopathy (often known simply as TMA) is a rare but serious medical disease. It is a pattern of damage that can occur in the smallest blood vessels inside many of your body’s vital organs – most commonly the kidney and brain. As a medical condition, TMA stands for thrombotic microangiopathy, a serious syndrome where tiny blood clots form in small blood vessels and damage organs.
Context Explanation
Thrombotic microangiopathy (TMA) is a serious medical condition that affects small blood vessels throughout the body. This complex disorder can lead to blood clot formation in small vessels, potentially causing damage to vital organs, particularly the kidneys. Thrombotic microangiopathies (TMA) are clinical syndromes defined by the presence of hemolytic anemia (destruction of red blood cells), low platelets, and organ damage due to the formation of microscopic blood clots in capillaries and small arteries. Thrombotic microangiopathy (TMA) is a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury.
Image Collection
Insight Material
[1] It may be seen in association with thrombocytopenia, anemia, purpura and kidney failure. Details of the evaluation and management of specific TMA syndromes including TTP and CM-TMA are presented in separate topic reviews on these syndromes, which are listed below. Thrombotic Microangiopathy (TMA) is a comprehensive term that describes syndromes with similar pathologic and clinical features. We use the term, "primary TMA syndromes," to describe the disorders for which there is evidence supporting a defined abnormality as the probably cause. Thrombotic microangiopathies (TMAs) are a group of potentially life-threatening conditions characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microvascular thrombi.